FTC’s Crackdown on Pharma Mergers Reflects ‘Tougher’ M&A Environment Under Biden Administration: Lawyer
March 22, 2021
By: Eric Sagonowsky
FiercePharma
Axinn partner Jeny Maier was quoted in the FiercePharma article, "FTC's Crackdown on Pharma Mergers Reflects 'Tougher' M&A Environment Under Biden Administration: Lawyer." This quote also appeared in the April 21, 2021 Forbes article, “After Roaring in 2020, Biotech Stocks Now Weighed Down By Merger Scrutiny, FDA Approval Delays and Possible Drug Pricing Legislation.”
Click here to access the article.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
CCWC 22nd Annual Career Strategies Conference
Sponsorship
Fordham Competition Law Institute's 53rd Annual Conference on International Antitrust Law and Policy, and Antitrust Economics Workshop
Sponsorship
Antitrust
Women, Influence, & Power in Law Conference 2026
Sponsorship
Antitrust
IP Litigation North America Summit 2026
Sponsorship
Intellectual Property
HNBA/VIA Annual Convention 2026
Sponsorship
Antitrust
30th Annual IBA Competition Conference
Speaking Engagement
Antitrust
ABA 2026 Antitrust Global Seminar Series
Speaking Engagement
Antitrust
Axinn Attorneys Earn Top Honors in Best Lawyers 2027
News
Antitrust
DOJ's Antitrust Division Remains Interested in Your Private Litigation
Byline Articles
Antitrust
Axinn Advises Thermo Fisher Scientific on Completed $1.075 Billion Sale of Microbiology Business to Astorg
Deals & Cases
Antitrust
